surpass cvot tirzepatide SURPASS-CVOT trial: was non-inferior to dulaglutide and superior to putative placebo for reducing the composite of CV death/HF events in patients with T2D and ASCVD. #AHA25 View the slides here: https://t.co/6VQpBHFP2I In patients with type 2

This review covers what it offers, what real customers say, how much it costs, and how it compares to more guided options like Ivy Rx

Even with higher copay plans, brand-name tirzepatide through insurance typically costs $100 to $300 per month, well below the retail price

However, this persistent effect also means tirzepatide may reduce the adaptive metabolic response that intermittent fasting traditionally triggers, potentially limiting some of fasting's cellular benefits like autophagy activation

Hair loss with Tirzepatide is rare and often related to rapid weight loss rather than the medication itself

One forum tells you to match doses